• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

    7/28/23 7:57:47 AM ET
    $ASXC
    $BLPH
    $COUR
    $ENPH
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASXC alert in real time by email

    Gainers

    • Unique Fabricating, Inc. (NASDAQ:UFAB) shares surged 62.6% to $0.3512 in pre-market trading after gaining 12% on Thursday.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) rose 34.3% to $0.6647 in pre-market trading after jumping 90% on Thursday.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) gained 29.3% to $6.58 in pre-market trading after the company announced a $138 million US government contract for oral and IV TPOXX treatment.
    • Homology Medicines, Inc. (NASDAQ:FIXX) shares gained 24.5% to $1.17 in pre-market trading after the company announced plans to evaluate strategic options. The company is also reducing its workforce by 87%.
    • Inpixon (NASDAQ:INPX) shares rose 20% to $0.2424 in pre-market trading after falling around 20% on Thursday. Inpixon recently agreed to merge with XTI Aircraft Company.
    • AEye, Inc. (NASDAQ:LIDR) shares climbed 17.8% to $0.2620 in pre-market trading after falling around 4% on Thursday.
    • Coursera, Inc. (NYSE:COUR) shares gained 15.3% to $15.00 in pre-market trading following better-than-expected second-quarter sales results. Cantor Fitzgerald upgraded Coursera from Neutral to Overweight and raised the price target from $13 to $17.
    • Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) rose 10.7% to $0.1030 in pre-market trading. Navidea Biopharmaceuticals named Craig A. Dais as CFO.
    • Intel Corporation (NASDAQ:INTC) shares rose 7.1% to $37.01 in pre-market trading after the company reported better-than-expected second-quarter results and issued strong guidance.
    • Asensus Surgical, Inc. (NYSE:ASXC) gained 7% to $0.3210 in pre-market trading. Asensus Surgical shares fell over 40% on Thursday after the company announced $10 million registered direct offering.

    Losers

    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) fell 39.3% to $1.08 in pre-market trading. Tonix Pharmaceuticals priced public offering of 7 million common shares at $1 per share.
    • Sleep Number Corporation (NASDAQ:SNBR) fell 28.8% to $27.39 in pre-market trading after the company reported mixed second-quarter results.
    • Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) fell 18.8% to $0.3702 in pre-market trading. Bellerophon Therapeutics recently received a delisting notice.
    • Mallinckrodt plc (NYSE:MNK) fell 17.3% to $1.34 in pre-market trading after jumping over 28% on Thursday.
    • Fresh Vine Wine, Inc. (NYSE:VINE) shares fell 15.1% to $0.5350 in pre-market trading. Fresh Vine Wine said on
    • July 14, Roger Cockroft's employment with and service as CEO of the company ended and Hitesh Dheri's employment with and service as CFO ended.
    • Enphase Energy, Inc. (NASDAQ:ENPH) shares fell 13.7% to $143.82 in pre-market trading after the company posted downbeat second-quarter sales and issued weak sales guidance.
    • Femasys Inc. (NASDAQ:FEMY) shares fell 13.5% to $0.7265 in pre-market trading. Femasys shares jumped over 130% on Thursday after the company announced that the United States Patent and Trademark Office issued a Notice of Allowance for FemBloc for permanent birth control.
    • Sigma Additive Solutions, Inc. (NASDAQ:SASI) fell 12.1% to $0.2022 in pre-market.
    • Sweetgreen, Inc. (NYSE:SG) fell 11% to $13.75 in pre-market trading after the company reported worse-than-expected second-quarter results.
    • Yoshiharu Global Co. (NASDAQ:YOSH) fell 10.6% to $0.59 in pre-market trading after dipping over 8% on Thursday.

     

    Now Read This: Intel, Procter & Gamble And 3 Stocks To Watch Heading Into Friday

    Get the next $ASXC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASXC
    $BLPH
    $COUR
    $ENPH

    CompanyDatePrice TargetRatingAnalyst
    Sweetgreen Inc.
    $SG
    3/9/2026Peer Perform
    Wolfe Research
    Sweetgreen Inc.
    $SG
    3/6/2026$5.50Neutral
    DA Davidson
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    More analyst ratings

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Sweetgreen

    Wolfe Research initiated coverage of Sweetgreen with a rating of Peer Perform

    3/9/26 9:11:59 AM ET
    $SG
    Restaurants
    Consumer Discretionary

    DA Davidson initiated coverage on Sweetgreen with a new price target

    DA Davidson initiated coverage of Sweetgreen with a rating of Neutral and set a new price target of $5.50

    3/6/26 8:36:44 AM ET
    $SG
    Restaurants
    Consumer Discretionary

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    $ASXC
    $BLPH
    $COUR
    $ENPH
    SEC Filings

    View All

    SEC Form 144 filed by Enphase Energy Inc.

    144 - Enphase Energy, Inc. (0001463101) (Subject)

    3/13/26 4:34:47 PM ET
    $ENPH
    Semiconductors
    Technology

    Tonix Pharmaceuticals Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)

    3/13/26 6:01:04 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Tonix Pharmaceuticals Holding Corp.

    10-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)

    3/12/26 5:29:52 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Concept Officer Jammet Nicolas bought $25,284 worth of shares (4,428 units at $5.71) (SEC Form 4)

    4 - Sweetgreen, Inc. (0001477815) (Issuer)

    3/9/26 5:55:54 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

    NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing. The forum featured CEO chats and company presentations from leadership teams representing innovative companies across the biotechnology, medical device, and pharmaceutical sectors, offering investors insights into emerging technologies, strategic initiatives, and growth opportunities within the life sciences industry. REGISTER AND VIEW PRESENTATIONS HERE The presentations will be available 24/7 for 90 days. Investors,

    3/13/26 8:35:00 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

    TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to patients, approximately 2,500 patients have initiated treatment with TONMYA, and cumulative prescriptions totaled approximately 4,200 Expect to initiate U.S. field study in 2027 for TNX-4800 for seasonal prevention of Lyme disease pending FDA clearance Completed $20.0 million registered direct offering with Point72 on December 29, 2025 Approximately $207.6 million in cash and cash equivalents as of December 31, 2025 BERKELEY HEIGHTS, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmac

    3/12/26 5:30:00 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sleep Number Redesigns Its Mattress Portfolio with Five Innovative New Beds That Adapt Night After Night as Customers' Needs Change

    Simplified Lineup Delivers Enhanced Comfort, Adjustability, Temperature Benefits and Value Across Three Collections: ComfortMode™, ComfortNext™ and Climate™ Sleep Number Corporation (NASDAQ:SNBR) today announced its largest product reset in almost a decade with the introduction of new, innovative beds designed to deliver a luxury experience at a more approachable price point. Available on March 23 online and in Sleep Number® stores, the five new beds offer superior comfort, personalized adjustability, temperature benefits and value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311848805/en/Sleep Number announced a redesig

    3/12/26 7:05:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Yang Mandy covered exercise/tax liability with 1,322 shares, decreasing direct ownership by 1% to 90,335 units (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    3/12/26 6:03:36 PM ET
    $ENPH
    Semiconductors
    Technology

    Chief Concept Officer Jammet Nicolas bought $25,284 worth of shares (4,428 units at $5.71) (SEC Form 4)

    4 - Sweetgreen, Inc. (0001477815) (Issuer)

    3/9/26 5:55:54 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    EVP, CFO Zinsner David converted options into 99,352 shares and covered exercise/tax liability with 49,260 shares, increasing direct ownership by 16% to 364,357 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    3/3/26 7:57:09 PM ET
    $INTC
    Semiconductors
    Technology

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Financials

    Live finance-specific insights

    View All

    Sleep Number Announces Fourth Quarter and Full Year 2025 Results

    Reports FY2025 Net Sales of $1.4 Billion, Exceeding Adjusted EBITDA Guidance Realized $185 Million of Annualized Cost Savings Launches New Products as the Next Phase of Turnaround Strategy to Return to Profitable Growth Sleep Number Corporation (NASDAQ:SNBR) today reported results for fourth quarter and the year ended January 3, 2026. Linda Findley, President and CEO, commented, "Sleep Number exceeded 2025 guidance provided on our last earnings call. We are still in full turnaround mode and made significant progress against our new product and marketing strategies while continuing to reduce costs. For the full year 2025, pro-forma adjusted EBITDA margin was approximately 9% and anti

    3/12/26 7:00:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update

    Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026  Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025. "In 2025, we continued to advance SIGA's key long-term priorities, including securing $27 million in additional U.S. Government funding to support development activities, while generating $88 million in product revenues and $24 million in pre-tax operating income," stated Diem

    3/10/26 4:01:00 PM ET
    $SIGA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sleep Number Corporation to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    Sleep Number Corporation (NASDAQ:SNBR) will release its fiscal fourth quarter and full year results through January 3, 2026, before market open on Thursday, March 12, 2026. Management will host its regularly scheduled conference call to discuss the company's results at 8:30 a.m. EDT (7:30 a.m. CDT; 5:30 a.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number® is the leader in personalized sleep wellness. Its mattresses are designed to evolve with each sleeper to help them feel and perform their best. With

    3/3/26 4:34:00 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Leadership Updates

    Live Leadership Updates

    View All

    After 20 Years, Sweetgreen Announces the Retirement of Co-Founder and Chief Brand Officer Nathaniel Ru

    Sweetgreen, Inc. (NYSE:SG), the mission-driven restaurant brand connecting more people to real food, today announced that, effective on January 1, 2026, Nathaniel Ru will be retiring from his role as Chief Brand Officer. Ru spent 20 years building the company. Ru will continue to serve as a member of the Board of Directors. "It's hard to put into words the emotions I feel looking back on how far we've come since those early days in Georgetown. What started as a simple yet powerful idea—to create a place where healthy, sustainable food was accessible to all—has grown into something far beyond what I ever imagined. I feel incredibly lucky to have brought this dream to life alongside some of

    12/17/25 4:30:00 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    Sleep Number Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Sleep Number Corporation (NASDAQ:SNBR) today announced that it granted an equity award on December 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Financial Officer, Amy O'Keefe. As previously disclosed, in connection with the appointment of O'Keefe as Executive Vice President and Chief Financial Officer effective December 8, 2025, Sleep Number granted O'Keefe an employment inducement award consisting of 69,742 shares in a time-vested restricted stock unit award that vests in three equal installments on each anniversary from the date of grant. The grants are subject to continued employment and the terms of the award agree

    12/15/25 4:01:00 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

    CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ms. Ishak will lead Tonix's legal, corporate governance, and compliance functions. "Irina is a highly accomplished corporate and commercial attorney whose experience spans public and private life sciences companies, as well as advising life sciences investors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "Her deep background in complex transactions, public company matters, and governa

    12/9/25 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASXC
    $BLPH
    $COUR
    $ENPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Sleep Number Corporation

    SC 13D/A - Sleep Number Corp (0000827187) (Subject)

    12/2/24 5:07:30 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Sleep Number Corporation

    SC 13D/A - Sleep Number Corp (0000827187) (Subject)

    11/25/24 6:54:27 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:42:22 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care